Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by FGPstockon Sep 20, 2022 10:55pm
243 Views
Post# 34975428

RE:RE:RE:RE:RE:RE:RE:RE:RE:Weak hands -

RE:RE:RE:RE:RE:RE:RE:RE:RE:Weak hands -
rob, i thought you were referring to a few weeks ago august. in my opinion, the 2019 financing was doomed from how they structures it. They announced a financing w o a price, any interested institution/individual could sell/short common shares knowing the had an allocation for the same amount or more shares when the price was set. Allowing warrants to trade day 1 wasn't the smartest move either as it gives the holder no incentive to exercise until expiration, meaning the company won't get the advantage of warrant $$$ until the have almost expired. So, I am not sue if the shorting was down by penny flippers, more likely sophisticated investors knowing they couldn't lose driving the price lower, then covering with their alloation in the financing, w a full warrant in addition. just my thoughts, i know bencro feels that financing and everything ever done by the company is brilliant. but, we are at 25c so he has that challenge to explain :)


<< Previous
Bullboard Posts
Next >>